» Articles » PMID: 16051736

Diagnosis and Management of Paroxysmal Nocturnal Hemoglobinuria

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2005 Jul 30
PMID 16051736
Citations 238
Authors
Affiliations
Soon will be listed here.
Citing Articles

Direct Oral Anticoagulants and Paroxysmal Nocturnal Hemoglobinuria: A Systematic Review and Update on Evidence.

Ali E, Al-Sadi A, Ali S, Rozi W, Idriss M, Jain M Cureus. 2025; 16(12):e76702.

PMID: 39898138 PMC: 11782904. DOI: 10.7759/cureus.76702.


[Clinical observation of allogeneic hematopoietic stem cell transplantation for treating five cases of classic paroxysmal nocturnal hemoglobinuria].

Zhao X, Zhang L, Zhang X, Hao M, Chen S, Wei J Zhonghua Xue Ye Xue Za Zhi. 2025; 45(12):1125-1128.

PMID: 39765354 PMC: 11886705. DOI: 10.3760/cma.cn121090-20240612-00221.


Current landscape of paroxysmal nocturnal hemoglobinuria in the era of complement inhibitors and regulators.

Shi J, Ozcan Y, Santos C, Patel H, Shammo J, Bat T Ther Adv Hematol. 2024; 15:20406207241307500.

PMID: 39734592 PMC: 11672493. DOI: 10.1177/20406207241307500.


Identifying Genes Associated With Proliferation, Immunity and Thrombosis in Paroxysmal Nocturnal Haemoglobinuria.

Du Y, Wang D, Hu Q, Lai Z, Yang C, He H J Cell Mol Med. 2024; 28(23):e70295.

PMID: 39671267 PMC: 11640899. DOI: 10.1111/jcmm.70295.


Monitoring and Treatment of Paroxysmal Nocturnal Hemoglobinuria in Patients with Aplastic Anemia in Asia: An Expert Consensus.

Wong R, Jang J, Wong L, Kim J, Rojnuckarin P, Goh Y Int J Mol Sci. 2024; 25(22).

PMID: 39596227 PMC: 11594386. DOI: 10.3390/ijms252212160.


References
1.
Tichelli A, Socie G, Marsh J, Barge R, Frickhofen N, McCann S . Outcome of pregnancy and disease course among women with aplastic anemia treated with immunosuppression. Ann Intern Med. 2002; 137(3):164-72. DOI: 10.7326/0003-4819-137-3-200208060-00008. View

2.
Diep D, Nelson K, Raja S, Pleshak E, Buckley J . Glycosylphosphatidylinositol anchors of membrane glycoproteins are binding determinants for the channel-forming toxin aerolysin. J Biol Chem. 1998; 273(4):2355-60. DOI: 10.1074/jbc.273.4.2355. View

3.
Bourantas K . High-dose recombinant human erythropoietin and low-dose corticosteroids for treatment of anemia in paroxysmal nocturnal hemoglobinuria. Acta Haematol. 1994; 91(2):62-5. DOI: 10.1159/000204254. View

4.
Araten D, Swirsky D, Karadimitris A, Notaro R, Nafa K, Bessler M . Cytogenetic and morphological abnormalities in paroxysmal nocturnal haemoglobinuria. Br J Haematol. 2001; 115(2):360-8. DOI: 10.1046/j.1365-2141.2001.03113.x. View

5.
Storb R, Evans R, Thomas E, Buckner C, Clift R, Fefer A . Paroxysmal nocturnal haemoglobinuria and refractory marrow failure treated by marrow transplantation. Br J Haematol. 1973; 24(6):743-50. DOI: 10.1111/j.1365-2141.1973.tb01701.x. View